Corona Vaccine and Treatment

FinancialLeader

Performance

  • +39.1 %
    since 2020-04-02
  • +33.6 %
    1 Year
  • +37.0 %
    Ø-Performance per year
All fees have already been deducted

Risk

  • -20.4 %
    Maximum loss (to date)
  • 0.54×
    Risk factor
Content after Login

You want access to all the information?

To see actual portfolio of this wikifolio, the performance-chart and sustainability-score please register now - for free.

Register

Trading Idea

This wikifolio should be investing in companies, which are present in the health sector. Investments will also be made in companies that are developing vaccines and Treatments for solving humanitarian problems and crises in a diversified manner.
This wikifolio is focusing on companies in the world doing R&D to develop and license a vaccine for diseases and humanitarian problems.
My opinion is that the first medical company coming up with a working vaccine or any news about this might have significant performance increase.
However, my expectation is that all other companies also might get production licenses most likely. The reason for this is the high demand and therefore the high amount of needed production capacity.
Like any other pharmaceutical company, a vaccine producer that get licenses might make an abnormal high amount of sales, this might give their stocks a big performance plus.
Mainly stocks can be traded. However, ETF´s and funds can be part of the trading as well.
Investment-horizon is mainly long. No day trading.
Buying decision of companies is based on the business mission, research if they are involved in vaccine development (short term: corona vaccine, long term: any such vaccine kind). Also the companies are being analysed based on their balance sheets, financial strength and the way their business model works. show more

Master data

Symbol
WF0CORVACC
Date created
2020-04-02
Index level
High watermark
141.1

Rules

wikifolio labels

Investment Universe

Trader

Markus Full
Registered since 2020-04-01

Decision making

  • Fundamental analysis
  • Other analysis